Results

Total Results: 904 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
    April 25, 2022 - Postpartum Care for Women Up to One Year After Pregnancy Evidence-based Practice Center … Systematic Review Protocol Project Title: Postpartum Care for Women Up to One Year After Pregnancy … 11.8).2 Approximately half (52%) of the deaths occurred in the postpartum period (defined as up to 1 year … after giving birth).2, 3 Additionally, up to 70,000 individuals per year in the U.S. experience severe … For KQ 1b: 3 months to 1 year after giving birth (except interpregnancy interval, unintended
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - ........................................................................................... 18 Author … P res c ribing Data For its large size (approximately 200,000 contact records per year), national scope … to year. … Report Number 12 18 Appendix The purpose of this appendix is to augment the detailed study description … of the TEP Further Description of Methods and Coding Further Description of Technical Expert Panel
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_research-protocol.pdf
    April 01, 2013 - Tumor (T) stages Stage Description T1 The tumor cannot be felt or seen using imaging techniques T1a … Lymph node (N) stages Stage Description NX Nearby lymph nodes were not assessed N0 The cancer has … publications reporting subgroups, other outcomes, longer followup) will be identified by examining author … meta-analyses are possible, meta-regression models will be used to analyze possible interactions with the year … OR (year ADJ old).ti,ab.) 10 Limit Limit 9 to English and humans and yr=“2007-Current” 11 Remove
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
    April 01, 2021 - Strategies for addressing insufficient evidence in evidence synthesis programs* Strategy Description … Example Example Description Reconsider eligible study designs In designing the original protocol … Example Example Description Summarize evidence on contextual factors (factors other than benefits … Example Example Description Incorporate health system data into a review Local health system data … Heart. 2010 Aug;96(16):1333; author reply doi: https://dx.doi.org/10.1136/hrt.2010.200758.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - Executive Summary There is a major problem with the demographic description of FVIIa use. … I believe that an accurate description of use would substantially change some of the introductory and … It also takes many months or more than a year to accomplish, so it is not as simple as desensitization … In the figure referred to by the author (Figures 7 to 18 in the report), we have presented the summary … estimates that the incidence of intracerebral hemorrhagic is 10% of the 795,000 stroke patients each year
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - to the systematic reviews found that among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain Strategy Description … Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the author … See Appendix B for detailed description of the criteria.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief2-opioid-withdrawal.pdf
    April 01, 2021 - to the systematic reviews found that among patients prescribed long-term opioid therapy in the last year … Studies of treatments to support opioid tapering in patients with chronic pain Strategy Description … Patient-centered prescription opioid tapering in community outpatients with chronic pain: 2- to 3-year … This report is made available to the public under the terms of a licensing agreement between the author … See Appendix B for detailed description of the criteria.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
    November 30, 2012 - These details are noted in the description of each study. 17 Peer Reviewer #3 General Comments … The following sentence was added to the Analytic Framework description: “For example, institutions … Provide a brief description of the search strategy used to identify relevant QI studies in the nursing … There is a very detailed description of the literature review process and it seems logical and comprehensive
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_disposition-comments.pdf
    May 04, 2015 - (I am co-author on that paper, and this was our main point, though the typing system was Dr. … about significant long-term outcomes such as exclusive breast-feeding at six months of age or at one year … on several important outcomes such as exclusive breast feeding by six months of age or until one year … We have added a brief description. … Hazelbaker, PhD, IBCLC, FILCA, CST, RCST) Introduction As to the HATLFF, as its author I must
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
    April 24, 2019 - I additionally refer you to the description of the CMMI Project, RAVEN. … TEP 4 Results The description of included studies (p. 12-14, w ith tables and f igures) w as clear, … Comment Response Public Commenter 3, Suzanne Gillespie References I additionally refer you to the description
  11. effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - It includes a reasonable background literature description, it provides definitions for relevant terminology … Did you follow this approach and if yes, revise this description to improve clarity. … We have revised some elements of the description of the ACTIVE trial. … We have revised our description of the booster assignment but it does not alter the bias conclusion … They do a good job with their description of how bias was rated.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - It includes a reasonable background literature description, it provides definitions for relevant terminology … Did you follow this approach and if yes, revise this description to improve clarity. … We have revised some elements of the description of the ACTIVE trial. … We have revised our description of the booster assignment but it does not alter the bias conclusion … They do a good job with their description of how bias was rated.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
    September 01, 2011 - the differentiation into Tiers 1-3 and MMD alone or mixed groups, I struggled to find a compelling description … Earlier this year, Janicak and colleagues published the results of a 6-month naturalistic follow-up … Peer Reviewer #8 General Nemeroff [et al., PNAS, 2003—and Michael Thase was a co-author] studied … "Two-year outcome of vagus nerve stimulation in treatment-resistant depression." … "Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes."
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
    January 01, 2020 - The table does not include any description of “time frame” as required by the PICOTS framework. … standard list to assess all potentially eligible studies, and do not go back in time to match the year … There is room in the first column if this could be explanded to Author, Year, Country, ROB. … TEP Reviewer 1 Discussion/ Conclusion Other comments Pg 113 Ln 16-18 The description of studies … The way it is written, the text sometimes conveys it was the author who did not analyze by subgroup
  15. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - These spreadsheets will allow each author to count key data points, such as study location, study type … evidence table will vary by key question, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
    June 30, 2016 - section on how we incorporated quality criteria for the systematic reviews into our inclusion and description … Tables can be copied and if they have a fuller description of what each contains via the title, the … TeleMental Health The number of veterans receiving care through telehealth is climbing by 22% each year … Riley, PhD, corresponding author Pamela Keberlein, RN, MSN, Gigi Sorenson, RN, MSN, Sailor Mohler … We revised the description of inclusion criteria to clarify that we did not restrict our inclusion to
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
    March 22, 2023 - considered normal for their age (e.g., a study on how to manage a toddler’s temper tantrum or an 8- year-old … Criteria for grading the risk of bias of individual studies Rating Description and Criteria Low • Least … Description of the strength of evidence grades Strength of Evidence Description High We are very confident … stable or that the estimate of effect is close to the true effect. 11 Strength of Evidence Description
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
    October 01, 2010 - evidence to show that adverse events associated with RFA are relatively uncommon….based on the study description … Nonrandomized studies of AF ablation that measured QoL outcomes were reviewed earlier this year.(1) … • This study evaluated 105 patients followed for one year. … RFA was superior to medical treatments at maintaining sinus rhythm in patients with PAF over one year
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - pre-existing conditions documented, are all identical to those reported in another study by the same author … We reworded the sample description to clarify that all subjects had recurrent CDI. … We reworded the sample description to clarify that all subjects had recurrent CDI Peer Reviewer #4 … PCP office in a flowchart method – IF patient presents with weight loss AND had surgery in the past yearDescription of studies evaluating risk factors for Clostridium difficile associated diarrhea (CDAD)

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: